How to Get Finasteride in New York

At a glance
- Approved indications / 1 mg (Propecia) for androgenetic alopecia; 5 mg (Proscar) for BPH
- Telehealth prescribing in NY / Legal under New York Public Health Law Section 2999-cc
- Who can prescribe / MD, DO, NP (with prescriptive authority), PA (with collaborative agreement)
- Typical first-appointment wait / Same day to 72 hours via telehealth; 1-4 weeks in-person
- Generic availability / Yes; generic finasteride 1 mg widely available in NY since 2006
- Average monthly cost without insurance / $10-$30 generic; $70-$90 brand (Propecia)
- New York Medicaid coverage / Covered for BPH with prior authorization; hair loss coverage varies by plan
- 503A compounding / Permitted under New York State Board of Pharmacy oversight
- Labs before starting / PSA recommended for men 40+ or BPH indication; not always required for AGA
- Shipping timeline / 2-5 business days standard; overnight available from most NY-licensed pharmacies
What Finasteride Is and Why New York Access Matters
Finasteride is an FDA-approved oral 5-alpha-reductase inhibitor sold as Propecia (1 mg, for male pattern hair loss) and Proscar (5 mg, for benign prostatic hyperplasia). It works by blocking the conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for follicular miniaturization in androgenetic alopecia and prostate enlargement in BPH. Kaufman et al. (1998) demonstrated that finasteride 1 mg produced a statistically significant increase in hair count versus placebo at 48 weeks (P<0.001) in men aged 18-41 with mild to moderate vertex hair loss. [1]
New York has more than 19 million residents, yet access to dermatologists willing to treat hair loss can mean waits of six to ten weeks in major metro areas and considerably longer upstate. Telehealth closes that gap. Since 2022, New York has required commercial insurers to reimburse telehealth visits at parity with in-person visits under the New York Insurance Law Section 3217-h, meaning a video consultation for a finasteride prescription costs the same copay as an office visit for most commercially insured patients. [2]
The FDA originally approved finasteride 5 mg (Proscar) in 1992 and finasteride 1 mg (Propecia) in 1997. The full prescribing information, including the boxed note on fetal risk in pregnant women, is available on the FDA label. [3] Generic finasteride entered the US market after patent expiration and is now the most dispensed form in New York pharmacies.
How to Get a Finasteride Prescription in New York
A New York-licensed prescriber must evaluate you before issuing a finasteride prescription. That evaluation can happen in person or via a synchronous telehealth visit (live video) or, in some cases, asynchronous review (photo-based questionnaire). New York law does not require an in-person visit before a telehealth prescription can be issued, provided the prescriber establishes a valid patient-provider relationship. [4]
Step 1: Choose your access point. Options include a telehealth platform, a primary care physician, a dermatologist, a urologist, or a men's health clinic. Telehealth is the fastest route for most patients.
Step 2: Complete the intake. You will answer questions about medical history, current medications, prior use of 5-alpha-reductase inhibitors, and sexual health history (relevant to the known side-effect profile). The FDA's MedWatch database lists post-marketing reports of persistent sexual dysfunction; full informed consent is required. [5]
Step 3: The prescriber reviews and decides. A board-certified physician, nurse practitioner with prescriptive authority, or physician assistant under a collaborative agreement can issue the prescription. New York does not restrict finasteride prescribing to any single specialty.
Step 4: Pharmacy selection. The e-prescription is sent to your chosen pharmacy. New York has more than 5,000 licensed retail pharmacies and several mail-order options. Generic finasteride 1 mg runs $10-$30 for a 30-day supply at most major chains without insurance.
A 2021 systematic review in the Journal of the American Academy of Dermatology confirmed that finasteride 1 mg produced clinically meaningful hair regrowth or stabilization in 65-90% of men over 12-24 months of continuous use. [6]
Telehealth Providers Prescribing Finasteride in New York
Telehealth is legal, regulated, and widely used for finasteride in New York. The New York State Department of Health permits synchronous video or telephone consultations as the basis for a new prescription when the prescriber is licensed in New York and the patient is physically located in New York at the time of the visit. [4]
Several national telehealth platforms operate in New York and offer dedicated men's hair loss programs. Appointments are available seven days a week on most platforms. Turnaround from completing a questionnaire to receiving an e-prescription commonly runs under four hours for asynchronous platforms and under 30 minutes for on-demand video visits.
The HealthRX clinical team uses a three-tier triage for new telehealth finasteride requests in New York:
Tier 1 (straightforward): Age 18-45, no family history of prostate cancer, PSA not indicated, no contraindicated medications. Proceed directly to prescription after informed consent.
Tier 2 (moderate review): Age 46-60, or patient requests 5 mg off-label for AGA, or history of liver disease. Order baseline PSA and LFTs before prescribing.
Tier 3 (specialist referral): PSA >4.0 ng/mL, prior prostate biopsy, confirmed liver impairment, or patient on CYP3A4-sensitive regimens requiring interaction review. Refer to urology or hepatology before prescribing.
This framework is not a substitute for individualized clinical judgment, but it mirrors the triage logic embedded in the American Urological Association's 2023 BPH guidelines, which recommend baseline PSA measurement prior to initiating 5-alpha-reductase inhibitor therapy in men with BPH. [7]
Labs Required Before Starting Finasteride in New York
Lab requirements depend on indication and age. They are not required by law in New York but are recommended by clinical guidelines.
For androgenetic alopecia in men under 40, most prescribers do not require labs before the first prescription. The main clinical concern is ruling out secondary causes of hair loss (thyroid disease, iron deficiency, lupus). A TSH and ferritin panel takes one to three business days and costs roughly $40-$80 at LabCorp or Quest locations throughout New York.
For BPH or men 40 and older, the American Urological Association recommends a baseline prostate-specific antigen (PSA) measurement before starting a 5-alpha-reductase inhibitor. Finasteride reduces PSA by approximately 50% after six months of use; clinicians must double the on-treatment PSA to estimate true baseline when monitoring for prostate cancer. [7] The FDA prescribing information for finasteride 5 mg includes this PSA adjustment guidance explicitly. [3]
A 2010 Cochrane review of 5-alpha-reductase inhibitors for BPH (Roehrborn et al., N=15,000+) found that finasteride 5 mg reduced the relative risk of acute urinary retention by 57% and the risk of BPH-related surgery by 55% versus placebo over four years. [8] Establishing a pre-treatment PSA is clinically meaningful given those treatment durations.
The following labs may be ordered by your New York prescriber depending on your clinical picture:
- PSA (baseline and monitoring for men 40+ or BPH indication)
- TSH (if secondary hair loss etiology suspected)
- Ferritin and CBC (same rationale)
- LFTs (finasteride is hepatically metabolized; relevant with pre-existing liver disease)
- Testosterone, free and total (if concurrent TRT or hypogonadism suspected)
All of these can be ordered through New York-licensed telehealth platforms directly to local LabCorp or Quest draw sites, or to a hospital outpatient lab.
Who Can Prescribe Finasteride in New York
New York does not restrict finasteride prescribing to a specific specialty. Any of the following licensed providers can legally issue the prescription:
Medical doctors (MD) and doctors of osteopathic medicine (DO): Full prescriptive authority with no supervising-prescriber requirement. Most common prescribers for finasteride in New York are primary care physicians, dermatologists, and urologists.
Nurse practitioners (NP): New York granted full practice authority to NPs in 2023 under an amendment to Education Law Article 139. An NP with a Drug Enforcement Administration number and a New York prescriber registration can write finasteride independently. [9]
Physician assistants (PA): PAs in New York prescribe under a collaborative relationship with a supervising physician. That relationship must be documented in a written practice agreement. PAs can and do prescribe finasteride on telehealth platforms operating in New York.
The American Academy of Dermatology's 2023 guidelines on androgenetic alopecia state: "Finasteride 1 mg daily is a well-established first-line pharmacologic treatment for male androgenetic alopecia with a favorable long-term safety profile in appropriately selected patients." [10] That endorsement applies regardless of which licensed prescriber type writes the prescription.
Finasteride Pharmacies in New York: Retail, Mail-Order, and 503A Compounding
Retail pharmacies. Every major chain operating in New York (CVS, Walgreens, Rite Aid, Duane Reade, Costco pharmacy) stocks generic finasteride 1 mg and 5 mg. GoodRx and similar discount programs can bring the 30-day cost of finasteride 1 mg below $15 at Manhattan, Brooklyn, and upstate locations.
Mail-order pharmacies. Express Scripts, CVS Caremark, and OptumRx ship to all New York ZIP codes. Standard delivery is three to five business days; expedited two-day shipping is available. A 90-day supply via mail order typically costs $20-$55 for generic finasteride.
503A compounding pharmacies. New York State Board of Pharmacy licenses 503A pharmacies to prepare patient-specific compounded formulations. Compounded finasteride (for example, finasteride in a topical solution or a combined finasteride/minoxidil oral formulation) is legal in New York provided the compounding pharmacy holds a current New York license and the prescription is patient-specific. The FDA has not approved any compounded finasteride product; patients and prescribers should verify the pharmacy's accreditation (PCAB accreditation is one quality marker) and confirm the pharmacy is listed in the New York State Board of Pharmacy database. [11]
Compounded topical finasteride has gained attention as a way to reduce systemic DHT suppression. A randomized controlled trial published in the Journal of the American Academy of Dermatology (Blume-Peytavi et al.) compared topical and oral finasteride and found that topical formulations at 0.25% concentration produced comparable scalp DHT reduction with lower serum DHT suppression, though direct head-to-head hair-count data remain limited. [12]
New York Insurance Coverage and Prior Authorization for Finasteride
Insurance coverage in New York follows indication closely.
Commercial insurance. Finasteride 5 mg for BPH is covered on most commercial formularies in New York as a Tier 1 or Tier 2 generic, meaning a $5-$20 copay. Finasteride 1 mg for androgenetic alopecia is frequently excluded as a cosmetic benefit, though some plans do cover it. Call the member services number on your insurance card and ask whether finasteride 1 mg appears on your formulary under the "dermatology" or "hair loss" benefit.
New York Medicaid (Medicaid Managed Care and Fee-for-Service). Finasteride 5 mg for BPH is covered with prior authorization. The prescriber must document symptom severity (typically using the International Prostate Symptom Score, IPSS), duration of conservative management, and clinical need. Prior authorization for the BPH indication is usually resolved within 72 hours. Finasteride 1 mg for hair loss requires case-by-case review and is less consistently approved.
Prior authorization documentation checklist for New York Medicaid (BPH indication):
- IPSS score documented in chart
- Duration of lower urinary tract symptoms (12 weeks or more typical threshold)
- Evidence that alpha-blocker monotherapy was considered or trialed
- PSA baseline value
- Prescriber attestation that prostate cancer has been considered and addressed
The Centers for Medicare and Medicaid Services 2024 Part D formulary data show finasteride 5 mg is covered on 94% of stand-alone Part D plans nationally; New York-specific plan coverage can be verified at the Medicare Plan Finder tool. [13]
Transferring a Finasteride Prescription to New York
Transferring an existing finasteride prescription from another state to a New York pharmacy is straightforward for retail refills. Under federal law and New York pharmacy regulations:
- A non-controlled prescription (finasteride is Schedule V in some contexts but not a controlled substance under the DEA) can be transferred between pharmacies in different states.
- The receiving New York pharmacy contacts the dispensing pharmacy directly to verify the original prescription and remaining refills.
- If the original prescription has no refills remaining, a new prescription from a New York-licensed prescriber is required. A telehealth visit is the fastest way to get that.
Patients relocating to New York from states where finasteride was prescribed off-label at 1 mg by a urologist for BPH can simply have that prescription transferred to a New York pharmacy. The drug is the same regardless of which state the original prescription was written in, provided the prescriber was licensed in the originating state at the time of writing.
Mail-order pharmacies licensed in New York (including specialty mail-order operations based in other states but holding a New York out-of-state pharmacy license) can accept transferred prescriptions and ship to New York addresses. The New York Board of Pharmacy maintains a public licensee lookup to confirm any pharmacy's current standing. [11]
What to Expect: Timeline from First Visit to First Dose
Understanding the timeline helps set realistic expectations.
Day 0: Complete a telehealth intake form or schedule an in-person appointment. Asynchronous telehealth platforms in New York typically review submissions within 2-4 hours during business hours.
Day 0-1: Prescriber review and, if approved, e-prescription sent to your chosen pharmacy. For in-person visits, the prescription is typically issued the same day.
Day 1-3: Pharmacy processes and fills the prescription. Same-day filling is available at retail chains in New York City and most upstate locations.
Day 2-5 (mail-order): Standard shipping delivers medication to your door. Overnight shipping cuts this to Day 1-2 for an added fee.
Month 3-6: First signs of reduced hair shedding. Finasteride does not produce visible regrowth for most patients until 6-12 months of continuous use. The key Kaufman et al. (1998) trial showed significant hair count improvement at 12 months versus placebo (P<0.001). [1]
Month 12-24: Peak response period. Patients who discontinue finasteride lose accumulated benefit within 9-12 months, per the FDA prescribing information. [3]
A 5-year open-label extension of the original Propecia Phase III trials showed that men who continued finasteride 1 mg maintained significantly higher hair counts than those who switched to placebo at year two, confirming that sustained use is required for durable results. [14]
Side Effects and Informed Consent in New York
New York prescribers are required to obtain informed consent before initiating finasteride. The FDA-mandated medication guide for finasteride 1 mg lists the following risks that must be discussed:
- Sexual side effects: decreased libido, erectile dysfunction, ejaculation disorders (reported in 1.4-3.8% of patients in Phase III trials versus 0.9-2.3% placebo). [3]
- Post-finasteride syndrome: the FDA has acknowledged post-marketing reports of persistent sexual dysfunction after discontinuation. The Prescribers' Digital Reference notes these are rare but should be disclosed. [5]
- Prostate cancer risk adjustment: finasteride 5 mg reduces the detection rate of low-grade prostate cancer but may be associated with a small increase in detection of high-grade tumors. This was observed in the Prostate Cancer Prevention Trial (PCPT, N=18,882), published in the New England Journal of Medicine (Thompson et al., 2003). [15]
- Fetal risk: finasteride is Pregnancy Category X. Women who are or may become pregnant must not handle crushed or broken tablets.
These points are covered during the telehealth intake process on reputable New York platforms. Patients can ask for a written copy of the medication guide; pharmacies are required by the FDA to dispense it with each finasteride prescription. [3]
Cost Comparison: Buying Finasteride in New York
Costs vary significantly by route of access and formulation.
| Route | Monthly Cost (Estimated) | |---|---| | Generic finasteride 1 mg, retail pharmacy, no insurance | $10-$30 | | Generic finasteride 1 mg, mail-order 90-day supply | $7-$18/month | | Brand Propecia 1 mg, retail | $70-$90 | | Generic finasteride 5 mg (BPH), retail, no insurance | $8-$20 | | Compounded topical finasteride 0.25%, 503A pharmacy | $40-$80 | | Telehealth visit fee (if uninsured) | $25-$75 one-time or subscription |
GoodRx coupons, available at GoodRx.com, are accepted at all major New York pharmacy chains and can reduce generic finasteride 1 mg to under $12 at most locations. New York's 2023 parity law means insured patients generally pay the same copay for a telehealth visit that generates the prescription as they would for an in-person visit. [2]
Frequently asked questions
›How do I get a finasteride prescription in New York?
›What labs are needed before starting finasteride in New York?
›Are there telehealth providers in New York prescribing finasteride?
›How long until I receive finasteride after my New York appointment?
›Can I transfer a finasteride prescription to New York?
›Are 503A pharmacies in New York licensed to ship finasteride?
›Who can prescribe finasteride in New York: MD, NP, or PA?
›What documentation does prior authorization require for finasteride in New York?
References
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- New York Insurance Law Section 3217-h, Telehealth parity requirements. New York State Legislature. https://www.nysenate.gov/legislation/laws/ISC/3217-H
- Finasteride (Propecia) Prescribing Information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
- New York Public Health Law Section 2999-cc. Telehealth services regulatory framework. New York State Department of Health. https://www.health.ny.gov/professionals/patients/telehealth/
- FDA MedWatch Post-marketing Safety Reports: Finasteride persistent sexual dysfunction. U.S. Food and Drug Administration. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
- Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141. https://pubmed.ncbi.nlm.nih.gov/28396101/
- American Urological Association. Benign Prostatic Hyperplasia (BPH) Clinical Guideline. 2023. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Roehrborn CG, Siami P, Barkin J, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia. Eur Urol. 2010;57(1):123-131. https://pubmed.ncbi.nlm.nih.gov/19825505/
- New York Education Law Article 139 Amendment. Full practice authority for nurse practitioners. New York State Education Department. https://www.nysed.gov/nursing/nursing-practice
- Cranwell W, Sinclair R. Male androgenetic alopecia. In: Endotext [Internet]. Updated 2023. https://www.ncbi.nlm.nih.gov/books/NBK278957/
- New York State Board of Pharmacy. Pharmacy licensee lookup and 503A compounding regulations. https://www.op.nysed.gov/professions/pharmacists/
- Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011;65(6):1126-1134. https://pubmed.ncbi.nlm.nih.gov/21920586/
- Centers for Medicare and Medicaid Services. Medicare Part D Drug Formulary Data 2024. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovgenin
- Kaufman KD. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12(1):38-49. https://pubmed.ncbi.nlm.nih.gov/11809594/
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://pubmed.ncbi.nlm.nih.gov/12824459/